Africa needs more genome sequencing to tackle new variants of SARS-CoV-2.

Otu, Akaninyene; Agogo, Emmanuel; Ebenso, Bassey

Otu, Akaninyene; Agogo, Emmanuel; Ebenso, Bassey.

Otu A; Department of Infection and Travel Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK. akanotu@yahoo.com.
Agogo E; College of Medical Sciences, University of Calabar, Calabar, Nigeria. akanotu@yahoo.com.
Ebenso B; Resolve to Save Lives, Abuja, Nigeria.

Nat Med ; 27(5): 744-745, 2021 05.

Article in English | MEDLINE | ID: covidwho-1172560

Subject(s)

COVID-19 Vaccines/therapeutic use; COVID-19/prevention & control; COVID-19/virology; SARS-CoV-2/genetics; Africa; Genome, Viral; High-Throughput Nucleotide Sequencing; Humans; Public-Private Sector Partnerships; Sequence Analysis, RNA

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2021 Document Type: Article Affiliation country: S41591-021-01327-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google